ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma (RAD001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00823459
Recruitment Status : Completed
First Posted : January 15, 2009
Last Update Posted : February 18, 2016
Sponsor:
Information provided by (Responsible Party):
Susan Chang, University of California, San Francisco

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2016
  Actual Study Completion Date : January 2016

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 May 24, 2017
June 22, 2017
2 July 31, 2017
August 30, 2017